Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 3
2004 2
2005 3
2006 2
2007 3
2008 3
2009 2
2010 3
2011 2
2012 4
2013 5
2014 10
2015 5
2016 11
2017 11
2018 18
2019 11
2020 10
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32349971

99 results
Results by year
Filters applied: . Clear all
Page 1
New treatments for peripheral artery disease.
Bartholomew J, Bishop GJ. Bartholomew J, et al. Cleve Clin J Med. 2020 May;87(5 suppl 1):21-25. doi: 10.3949/ccjm.87.s1.03. Cleve Clin J Med. 2020. PMID: 32349971 Free article.
Peripheral Arterial Disease – Diagnosis and Treatment: A Systematic Review [Internet].
Swedish Council on Health Technology Assessment. Swedish Council on Health Technology Assessment. Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Nov. SBU Yellow Report No. 187. Swedish Council on Health Technology Assessment (SBU). 2008. PMID: 28876730 Free Books & Documents. Review.
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators. Anand SS, et al. Lancet. 2018 Jan 20;391(10117):219-229. doi: 10.1016/S0140-6736(17)32409-1. Epub 2017 Nov 10. Lancet. 2018. PMID: 29132880 Free article. Clinical Trial.
Gene therapy for peripheral arterial disease.
Forster R, Liew A, Bhattacharya V, Shaw J, Stansby G. Forster R, et al. Cochrane Database Syst Rev. 2018 Oct 31;10(10):CD012058. doi: 10.1002/14651858.CD012058.pub2. Cochrane Database Syst Rev. 2018. PMID: 30380135 Free PMC article. Review.
Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, Kuder J, Murphy SA, Jukema JW, Lewis BS, Tokgozoglu L, Somaratne R, Sever PS, Pedersen TR, Sabatine MS. Bonaca MP, et al. Circulation. 2018 Jan 23;137(4):338-350. doi: 10.1161/CIRCULATIONAHA.117.032235. Epub 2017 Nov 13. Circulation. 2018. PMID: 29133605 Free article. Clinical Trial.
Growth factors for angiogenesis in peripheral arterial disease.
Gorenoi V, Brehm MU, Koch A, Hagen A. Gorenoi V, et al. Cochrane Database Syst Rev. 2017 Jun 8;6(6):CD011741. doi: 10.1002/14651858.CD011741.pub2. Cochrane Database Syst Rev. 2017. PMID: 28594443 Free PMC article. Review.
Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
Armstrong EJ, Chen DC, Westin GG, Singh S, McCoach CE, Bang H, Yeo KK, Anderson D, Amsterdam EA, Laird JR. Armstrong EJ, et al. J Am Heart Assoc. 2014 Apr 10;3(2):e000697. doi: 10.1161/JAHA.113.000697. J Am Heart Assoc. 2014. PMID: 24721799 Free PMC article.
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.
Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Goto S, Ohman EM, Elbez Y, Sritara P, Baumgartner I, Banerjee S, Creager MA, Bhatt DL; REACH Registry Investigators. Kumbhani DJ, et al. Eur Heart J. 2014 Nov 1;35(41):2864-72. doi: 10.1093/eurheartj/ehu080. Epub 2014 Feb 28. Eur Heart J. 2014. PMID: 24585266 Free PMC article.
99 results
Jump to page